Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
bionanotechnology
Pharma
Salvat heads to regulators with phase 3 data on ocular steroid
Salvat is gearing up to launch an ocular corticosteroid for inflammation and pain in cataract surgery patients after finishing phase 3 trials.
Nick Paul Taylor
Apr 12, 2022 7:34am
Houston Methodist researchers get $4M grant to study HIV drug delivery
Jul 18, 2016 11:06pm
Aphios reels in nanoformulation of a new cancer-fighting drug
Jul 18, 2016 8:03am
NJ Institute of Technology nabs $1M grant for nanotechnology
Jul 11, 2016 2:32pm
Researchers at Sloan Kettering uncover new way to target drugs to cancer sites
Jul 11, 2016 12:13pm
Mathematical model combines drugs with a nanoparticle to treat cancer
Jun 28, 2016 8:05am
